EC ever use among women of reproductive age: 0.2% (DHS 2005)
EC knowledge among women of reproductive age: 13.0% (DHS 2010-11)
Contraceptive Use: 8.9% (DHS 2010-11, ever use of a modern method among women of reproductive age)
Registered LNG-EC products:
- Duet - Available only with prescription
- NorLevo 1.5mg* - Available only with prescription
- Optinor - Available only with prescription
Registered UPA-EC products:
- ellaOne* - Available only with prescription
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Public sector clinics, Private clinics, Pharmacies, IPPF-affiliated system
Age restrictions for accessing ECPs: No
Legal/regulatory documents in which EC is included: National FP Norms, Essential Medicines List
Pricing information: LNG Products: $7.50 (3,623 CFA Franc), as of June 2014.
UPA Products: $10.36 (5,000 CFA Franc), as of June 2014.
Other relevant information: A prescription is not always requested by pharmacies in order to purchase.
EC distributed via IPPF outlets (<500 in 2012).
In Senegal, the lowest cadre of health workers allowed to sell/dispense ECPs in the public sector is auxiliary nurses. The lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is auxiliary nurses. (Data as of 2013.) (USAID/DELIVER, Contraceptive Security Indicators, 2013)
In 2013, EC was procured by the government. No stock-outs were reported at the central level (JSI/Deliver data).
For more information, see below: